Skip to content

Mediators of Atherosclerosis in South Asians Living in America

Mediators of Atherosclerosis in South Asians Living in America

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01207167
Acronym
MASALA
Enrollment
2314
Registered
2010-09-22
Start date
2010-09-01
Completion date
2027-04-01
Last updated
2026-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis, Cardiovascular Diseases, Coronary Artery Disease, Coronary Disease, Heart Diseases

Brief summary

South Asian (Indian, Pakistani, Bangladeshi, Nepali, and Sri Lankan) individuals have high rates of cardiovascular disease that is not explained by traditional cardiovascular risk factors. Though South Asians represent over one-quarter of the world's population, there are no longitudinal studies in this high-risk ethnic group. The investigators aim to establish a longitudinal study of South Asians at three United States centers to identify risk factors linked to subclinical atherosclerosis and incident cardiovascular disease. The purpose of this study is to understand the causes of heart disease and stroke in South Asians and compare these causes to those in other United States ethnic groups.

Interventions

None listed

Sponsors

University of California, San Francisco
Lead SponsorOTHER
Northwestern University
CollaboratorOTHER
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH
New York University
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 84 Years
Healthy volunteers
No

Inclusion criteria

* South Asian ancestry defined by having at least 3 grandparents born in one of the following countries: India, Pakistan, Bangladesh, Nepal, or Sri Lanka * age between 40 and 84 years.

Exclusion criteria

* Physician diagnosed heart attack, stroke or transient ischemic attack (TIA), heart failure, or angina (or use of nitroglycerin) * Current atrial fibrillation * Past history of cardiovascular procedures (coronary artery bypass graft (CABG) Surgery, angioplasty, valve replacement, pacemaker or defibrillator implantation, or any surgery on the heart or arteries) * Active treatment for cancer * Life expectancy less than 5 years due to serious medical illness * Impaired cognitive ability as judged by the reviewer * Plans to move out of the study region in next 5 years * Weight greater than 300 pounds * Living in a nursing home or on a waiting list * Unable to speak/read/write English, Hindi, Urdu, or Bangla

Design outcomes

Primary

MeasureTime frame
Coronary artery calcium prevalence in South AsiansBaseline

Secondary

MeasureTime frame
Change from baseline Coronary artery calcium prevalence in South Asians at 4 yearsBaseline to Year 4
Incidence of type 2 diabetes after approximately 4 years of follow-upBaseline to Year 4
Carotid intima media thicknessBaseline
Diabetes PrevalenceBaseline

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAlka Kanaya, MD

University of California, San Francisco

PRINCIPAL_INVESTIGATORNamratha Kandula, MD

Northwestern University

PRINCIPAL_INVESTIGATORNadia Islam, PhD

New York University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026